Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Patient Treatment Study for the Use of XL999 Administered Intravenously to a Subject With Advanced Malignancies Previously Enrolled in Study XL999-900

NCT01945164 is registered in ClinicalTrials.gov with John Sarantopoulos as lead sponsor.

NCT NCT01945164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01945164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Patient Treatment Study for the Use of XL999 Administered Intravenously to a Subject With Advanced Malignancies Previously Enrolled in Study XL999-900
Lead sponsor
John Sarantopoulos
Phase
Expanded access
Overall status
No longer available
Start date
April 30, 2010
Completion date
June 30, 2012
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignancy